Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.
Latest News
February 1, 2010Pearl Therapeutics Raises $15 Million to...
January 6, 2010Pearl Therapeutics Announces Positive...
January 4, 2010Pearl Therapeutics Announces Positive...
More Press Releases